Goldman Sachs’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,551
Closed -$13.2K 6185
2024
Q3
$13.2K Buy
+14,551
New +$13.6K ﹤0.01% 5693
2021
Q3
Sell
-14,999
Closed -$37K 6403
2021
Q2
$37K Sell
14,999
-13,224
-47% -$32.1K ﹤0.01% 6099
2021
Q1
$101K Buy
28,223
+53
+0.2% +$182 ﹤0.01% 5845
2020
Q4
$60K Buy
28,170
+1,595
+6% +$2.81K ﹤0.01% 5356
2020
Q3
$37K Buy
26,575
+5,627
+27% +$9.81K ﹤0.01% 5214
2020
Q2
$41K Buy
+20,948
New +$38.4K ﹤0.01% 5081

Other funds holding MLSS

Goldman Sachs's MLSS Position: Q4 2024 in Review

Goldman Sachs sold out of Milestone Scientific (MLSS) in Q4 2024, closing a stake of 14,551 shares — an estimated $13.2K sold.

Goldman Sachs first reported a position in MLSS in Q2 2020 and held it in 6 quarters. The position peaked at $101K in Q1 2021. 35 funds tracked by Wall St. Rank hold MLSS as of Q4 2024.

  • Goldman Sachs reported no remaining Milestone Scientific position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 14,551 Milestone Scientific shares in Q4 2024, an estimated $13.2K.
  • Goldman Sachs first reported a position in Milestone Scientific in Q2 2020 and held it in 6 quarters.
  • Goldman Sachs's Milestone Scientific position peaked at $101K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.